Gerald E Quirk - Net Worth and Insider Trading
Gerald E Quirk Net Worth
The estimated net worth of Gerald E Quirk is at least $0 dollars as of 2026-08-16. Gerald E Quirk is the Chief Legal & Compliance Offic of Syros Pharmaceuticals Inc and owns about 0 shares of Syros Pharmaceuticals Inc (SYRS) stock worth over $0. Details can be seen in Gerald E Quirk's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Gerald E Quirk has not made any transactions after 2024-11-19 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Gerald E Quirk
Gerald E Quirk Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Gerald E Quirk owns 3 companies in total, including Syros Pharmaceuticals Inc (SYRS) , Eledon Pharmaceuticals Inc (ELDN) , and Infinity Pharmaceuticals Inc (INFIQ) .
Click here to see the complete history of Gerald E Quirk’s form 4 insider trades.
Insider Ownership Summary of Gerald E Quirk
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2024-11-19 | Chief Legal & Compliance Offic |
| ELDN | Eledon Pharmaceuticals Inc | 2015-05-26 | General Counsel & Executive VP |
| INFIQ | Infinity Pharmaceuticals Inc | 2010-01-01 | VP,Cor. Affairs & Gnrl Counsel |
Gerald E Quirk Latest Holdings Summary
Gerald E Quirk currently owns a total of 1 stock. Gerald E Quirk owns 0 shares of Syros Pharmaceuticals Inc (SYRS) as of November 19, 2024, with a value of $0.
Latest Holdings of Gerald E Quirk
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SYRS | Syros Pharmaceuticals Inc | 2024-11-19 | 0 | 0.00 | 0 |
Holding Weightings of Gerald E Quirk
Gerald E Quirk Form 4 Trading Tracker
According to the SEC Form 4 filings, Gerald E Quirk has made a total of 1 transactions in Syros Pharmaceuticals Inc (SYRS) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Syros Pharmaceuticals Inc is the sale of 46,657 shares on November 19, 2024, which brought Gerald E Quirk around $10,265.
Insider Trading History of Gerald E Quirk
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Gerald E Quirk Trading Performance
Gerald E Quirk Ownership Network
Ownership Network List of Gerald E Quirk
Ownership Network Relation of Gerald E Quirk
Gerald E Quirk Owned Company Details
What does Syros Pharmaceuticals Inc do?
Who are the key executives at Syros Pharmaceuticals Inc?
Gerald E Quirk is the Chief Legal & Compliance Offic of Syros Pharmaceuticals Inc. Other key executives at Syros Pharmaceuticals Inc include Chief Medical Officer David Roth , Chief Development Officer Kristin Stephens , and director & President & CEO Chee Conley .
Syros Pharmaceuticals Inc (SYRS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Syros Pharmaceuticals Inc (SYRS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Syros Pharmaceuticals Inc (SYRS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Syros Pharmaceuticals Inc (SYRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Syros Pharmaceuticals Inc Insider Transactions
Gerald E Quirk Mailing Address
Above is the net worth, insider trading, and ownership report for Gerald E Quirk. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Gerald E Quirk's mailing address is: Cambridge Ma 02139.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
